Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Hims Hers Health Inc(HIMS)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HIMS
09/15/2026: HIMS (2-star) is currently NOT-A-BUY. Pass it for now.
Hims & Hers is a digital health company that leverages a direct-to-consumer subscription model to provide access to telehealth and personalized wellness products. Its main strengths include a recognizable brand and an efficient user experience that drives high subscriber retention. The company's primary growth story centers on its expansion into high-demand areas like GLP-1 weight loss and chronic condition management. However, it faces significant risks from stiff competition, regulatory scrutiny over telehealth practices, and potential margin compression in commoditized markets. The stock may suit growth-oriented investors who can tolerate high volatility while monitoring the company's ability to maintain sustainable profit margins and regulatory compliance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company shows high top-line growth potential in the expanding digital health and wellness market. |
| Momentum investor | Strong fit while signal remains positive | Strong revenue growth and market interest often lead to significant price momentum in this stock. |
| Value investor | Weak fit | The company is not currently valued based on traditional value metrics like P/E, given its growth-at-all-costs phase. |
| Dividend investor | Weak fit | The company does not pay a dividend and prioritizes capital reinvestment. |
| Low-risk investor | Weak fit | The high volatility and regulatory risks make this unsuitable for risk-averse investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is prone to sharp swings based on growth narratives and market conditions. |
| Valuation risk | Medium / high | High growth expectations are priced into the stock, leaving little margin for error. |
| Competition risk (Telehealth incumbents) | High | Heavy competition from well-capitalized retailers and specialized telehealth peers threatens market share. |
| Business quality | Medium | The reliance on online marketing and generic commoditized products creates a challenging moat. |
| Dividend income | Low / none | Investors should not expect income from this equity. |
| Execution risk | Medium / high | Success depends on rapidly launching and scaling new health categories while maintaining quality. |
Price Behavior
Rolling Over
The price momentum is slowing down and beginning to turn downward.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit 112.37% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 09/15/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 6.72B USD | Price to earnings Ratio - | 1Y Target Price 31.29 |
Price to earnings Ratio - | 1Y Target Price 31.29 | ||
Volume (30-day avg) 11.4M shares | Beta 2.41 | 52 Weeks Range 13.74 - 65.30 | Updated Date 09/15/2026 |
52 Weeks Range 13.74 - 65.30 | Updated Date 09/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.64 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| DTC Subscriptions | Monthly recurring fees for consultations and medications. | Most revenue comes from recurring subscription plans, providing predictable cash flow. |
| Telehealth Consultations | Platform fees and clinical services access. | The company earns revenue by connecting users to medical experts via its platform. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 71.43 | Enterprise Value 7.43B | Price to Sales(TTM) 2.61 |
Enterprise Value 7.43B | Price to Sales(TTM) 2.61 | ||
Enterprise Value to Revenue 2.76 | Enterprise Value to EBITDA 205.86 | Shares Outstanding 224.94M | Shares Floating 213.69M |
Shares Outstanding 224.94M | Shares Floating 213.69M | ||
Percent Insiders 4.97 | Percent Institutions 71.47 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Hims Hers Health Inc
Exchange NYSE | Headquarters San Francisco, CA, United States | ||
IPO Launch date 2019-09-13 | Co-Founder, Chairman & CEO Mr. Andrew Dudum | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 2442 | Website https://www.hims.com |
Full time employees 2442 | Website https://www.hims.com | ||
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.